Función pancreática exocrina en diabetes mellitus: Determinación de elastasa fecal

Background: One of the complications of diabetes mellitus is the development of pancreatic exocrine insufficiency. Aim: To study pancreatic exocrine function in diabetics patients. Material and methods: Seventy two diabetic patients were included in the protocol, but two were withdrawn because an ab...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mancilla A,Carla, Hurtado H,Carmen, Tobar A,Eduardo, Orellana N,Ivonne, Pineda B,Pedro, Castillo M,Iván, Ledezma R,Rodrigo, Berger F,Zoltán
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2006
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006000400001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872006000400001
record_format dspace
spelling oai:scielo:S0034-988720060004000012014-01-23Función pancreática exocrina en diabetes mellitus: Determinación de elastasa fecalMancilla A,CarlaHurtado H,CarmenTobar A,EduardoOrellana N,IvonnePineda B,PedroCastillo M,IvánLedezma R,RodrigoBerger F,Zoltán Diabetes mellitus Pancreatic elastase Pancreatitis, chronic Background: One of the complications of diabetes mellitus is the development of pancreatic exocrine insufficiency. Aim: To study pancreatic exocrine function in diabetics patients. Material and methods: Seventy two diabetic patients were included in the protocol, but two were withdrawn because an abdominal CAT scan showed a chronic calcified pancreatitis, previously undiagnosed. Fecal elastase was measured by ELISA and the presence of fat in feces was assessed using the steatocrit. Results: Mean age was 60±12 years and 67 (96%) patients had a type 2 diabetes. Fecal elastase was normal (elastase >200 µg/g) in 47 (67%) patients, mildly decreased (100-200 µg/g) in 10 (14%) and severely decreased in 13 (19%). There was a significant association between elastase levels and time of evolution of diabetes (p=0.049) and between lower elastase levels and the presence of a positive steatocrit (p=0.042). No significant association was found between elastase levels and other chronic complications of diabetes such as retinopathy, nephropathy, neuropathy, microangiopathy or with insulin requirement. Conclusions: One third of this group of diabetic patients had decreased levels of fecal elastase, that was associated with the time of evolution of diabetes. Patients with lower levels of elastase have significantly more steatorrhea. Among diabetics it is possible to find a group of patients with non diagnosed chronic pancreatitisinfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.134 n.4 20062006-04-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006000400001es10.4067/S0034-98872006000400001
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Diabetes mellitus
Pancreatic elastase
Pancreatitis, chronic
spellingShingle Diabetes mellitus
Pancreatic elastase
Pancreatitis, chronic
Mancilla A,Carla
Hurtado H,Carmen
Tobar A,Eduardo
Orellana N,Ivonne
Pineda B,Pedro
Castillo M,Iván
Ledezma R,Rodrigo
Berger F,Zoltán
Función pancreática exocrina en diabetes mellitus: Determinación de elastasa fecal
description Background: One of the complications of diabetes mellitus is the development of pancreatic exocrine insufficiency. Aim: To study pancreatic exocrine function in diabetics patients. Material and methods: Seventy two diabetic patients were included in the protocol, but two were withdrawn because an abdominal CAT scan showed a chronic calcified pancreatitis, previously undiagnosed. Fecal elastase was measured by ELISA and the presence of fat in feces was assessed using the steatocrit. Results: Mean age was 60±12 years and 67 (96%) patients had a type 2 diabetes. Fecal elastase was normal (elastase >200 µg/g) in 47 (67%) patients, mildly decreased (100-200 µg/g) in 10 (14%) and severely decreased in 13 (19%). There was a significant association between elastase levels and time of evolution of diabetes (p=0.049) and between lower elastase levels and the presence of a positive steatocrit (p=0.042). No significant association was found between elastase levels and other chronic complications of diabetes such as retinopathy, nephropathy, neuropathy, microangiopathy or with insulin requirement. Conclusions: One third of this group of diabetic patients had decreased levels of fecal elastase, that was associated with the time of evolution of diabetes. Patients with lower levels of elastase have significantly more steatorrhea. Among diabetics it is possible to find a group of patients with non diagnosed chronic pancreatitis
author Mancilla A,Carla
Hurtado H,Carmen
Tobar A,Eduardo
Orellana N,Ivonne
Pineda B,Pedro
Castillo M,Iván
Ledezma R,Rodrigo
Berger F,Zoltán
author_facet Mancilla A,Carla
Hurtado H,Carmen
Tobar A,Eduardo
Orellana N,Ivonne
Pineda B,Pedro
Castillo M,Iván
Ledezma R,Rodrigo
Berger F,Zoltán
author_sort Mancilla A,Carla
title Función pancreática exocrina en diabetes mellitus: Determinación de elastasa fecal
title_short Función pancreática exocrina en diabetes mellitus: Determinación de elastasa fecal
title_full Función pancreática exocrina en diabetes mellitus: Determinación de elastasa fecal
title_fullStr Función pancreática exocrina en diabetes mellitus: Determinación de elastasa fecal
title_full_unstemmed Función pancreática exocrina en diabetes mellitus: Determinación de elastasa fecal
title_sort función pancreática exocrina en diabetes mellitus: determinación de elastasa fecal
publisher Sociedad Médica de Santiago
publishDate 2006
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006000400001
work_keys_str_mv AT mancillaacarla funcionpancreaticaexocrinaendiabetesmellitusdeterminaciondeelastasafecal
AT hurtadohcarmen funcionpancreaticaexocrinaendiabetesmellitusdeterminaciondeelastasafecal
AT tobaraeduardo funcionpancreaticaexocrinaendiabetesmellitusdeterminaciondeelastasafecal
AT orellananivonne funcionpancreaticaexocrinaendiabetesmellitusdeterminaciondeelastasafecal
AT pinedabpedro funcionpancreaticaexocrinaendiabetesmellitusdeterminaciondeelastasafecal
AT castillomivan funcionpancreaticaexocrinaendiabetesmellitusdeterminaciondeelastasafecal
AT ledezmarrodrigo funcionpancreaticaexocrinaendiabetesmellitusdeterminaciondeelastasafecal
AT bergerfzoltan funcionpancreaticaexocrinaendiabetesmellitusdeterminaciondeelastasafecal
_version_ 1718436254247288832